A0A2I3TJ11 (A0A2I3TJ11_PANTR) Pan troglodytes (Chimpanzee)
Bromodomain containing 4 UniProtKBInterProSTRINGInteractive Modelling
1362 aa; Sequence (Fasta) ;
2 identical sequences: Homo sapiens: O60885; Pan troglodytes: A0A6D2Y7V9
It is possible new templates exist for this target since these models were created.
Available Structures
554 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Ternary structure of intramolecular bivalent glue degrader IBG1 bound to BRD4 and DCAF16:DDB1deltaB… |
Heteromer O60885; Q16531; Q9NXF7; | 1×ZN; 1×U79; | ||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 in complex with dual-acetylated SARS-CoV-2 E |
Heteromer O60885; P0DTC4; | |||||
| Assess | ||||||
| Crystal Structure of Brd4 Bromodomain 1 in Complex with Acetylated Rel Peptide |
Heteromer O60885; Q04206; | |||||
| Assess | ||||||
| Solution structures of second bromodomain of Brd4 with di-acetylated Twist peptide |
Heteromer O60885; Q15672; | |||||
| Assess | ||||||
| solution structures of BRD4 second bromodomain with NF-kB-K310ac peptide |
Heteromer O60885; Q04206; | |||||
| Assess | ||||||
| NMR solution structures of second bromodomain of BRD4 with FOXO3a peptide |
Heteromer O43524; O60885; | |||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with an acetylated POLR2A pepti… |
Heteromer O60885; P24928; | 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with an acetylated SIRT7 peptid… |
Heteromer O60885; Q9NRC8; | 3×EDO; | ||||
| Assess | ||||||
| Crystal structure of DDB1-CRBN-BRD4(BD1) complex bound to dBET6 PROTAC. |
Heteromer O60885; Q16531; Q96SW2; | 1×ZN; 1×RN6; | ||||
| Assess | ||||||
| Crystal structure of DDB1-CRBN-BRD4(BD1) complex bound to dBET23 PROTAC. |
Heteromer O60885; Q16531; Q96SW2; | 1×ZN; 1×RN3; | ||||
| Assess | ||||||
| Crystal structure of DDB1-CRBN-BRD4(BD1) complex bound to dBET70 PROTAC |
Heteromer O60885; Q16531; Q96SW2; | 1×ZN; | ||||
| Assess | ||||||
| Crystal structure of DDB1-CRBN-BRD4(BD1) complex bound to dBET57 PROTAC |
Heteromer O60885; Q16531; Q96SW2; | 1×ZN; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with an acetylated E2F1 peptide… |
Heteromer O60885; Q01094; | 1×EDO; | ||||
| Assess | ||||||
| BRD4-BD1 in complex with the cyclic peptide 3.2_1 |
Heteromer O60885; | 1×NH2; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with an acetylated BAZ1B peptid… |
Heteromer O60885; Q9UIG0; | |||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with an acetylated SRPK1 peptid… |
Heteromer O60885; Q96SB4; | 2×EDO; | ||||
| Assess | ||||||
| Crystal structure of human Bromodomain containing protein 4 (BRD4) in complex with SHMT |
Heteromer O60885; P34896; | 1×EDO; 8×NA; 4×CL; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a diacetylated histone 4 p… |
Heteromer O60885; P62805; | 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with an acetylated GATA1 peptid… |
Heteromer O60885; P15976; | 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with an acetylated ATRX peptide… |
Heteromer O60885; P46100; | 3×EDO; | ||||
| Assess | ||||||
| Crystal structure of human Bromodomain containing protein 4 (BRD4) in complex with BCLTF1 |
Heteromer O60885; Q9NYF8; | 1×EDO; 1×NA; | ||||
| Assess | ||||||
| Ternary complex between VCB, BRD4-BD1 and PROTAC 48 |
Heteromer O60885; P40337; Q15369; Q15370; | 4×SO4; 6×EDO; 1×QIY; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a diacetylated histone 4 p… |
Heteromer O60885; P62805; | 2×NA; 1×EDO; 3×FMT; | ||||
| Assess | ||||||
| Ternary complex of VHL/BRD4-BD1/Compound9 (4-(3,5-difluoropyridin-2-yl)-N-(11-(((S)-1-((2S,4R)-4-hy… |
Heteromer O60885; P40337; Q15369; Q15370; | 1×WEP; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a diacetylated histone 4 p… |
Heteromer O60885; P62805; | |||||
| Assess | ||||||
| BRD4-BD1 in complex with the a diacetylated-E2F1 peptide |
Heteromer O60885; Q01094; | |||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 in complex with monoacetylated SARS-CoV-2 E |
Heteromer O60885; P0DTC4; | |||||
| Assess | ||||||
| Ternary complex between VCB, BRD4-BD1 and PROTAC 49 |
Heteromer O60885; P40337; Q15369; Q15370; | 1×SO4; 1×QIK; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a diacetylated TOP2A pepti… |
Heteromer O60885; P11388; | 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of human Bromodomain containing protein 4 (BRD4) in complex with hnRNPK |
Heteromer O60885; P61978; | 1×NA; 2×GOL; 2×ACT; | ||||
| Assess | ||||||
| Human BRD4 bromdomain 1 in complex with a H4 peptide containing ApmTri (H4K5/8ApmTri) |
Heteromer O60885; P62805; | |||||
| Assess | ||||||
| Crystal structure of human Bromodomain containing protein 4 (BRD4) in complex with ILF3 |
Heteromer O60885; Q12906; | 5×NA; 3×CL; 1×EDO; | ||||
| Assess | ||||||
| Human BRD4 bromdomain 1 in complex with a H4 peptide containing acetyl lysine and ApmTri (H4K5acK8A… |
Heteromer O60885; P62805; | |||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a diacetylated histone 4 p… |
Heteromer O60885; P68431; | |||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a diacetylated histone 4 p… |
Heteromer O60885; P68431; | 1×EDO; | ||||
| Assess | ||||||
| Open non-crosslinked structure Brd4BD2-MZ1-(NEDD8)-CRL2VHL |
Heteromer L7N190; O60885; P40337; Q13617; Q15370; | 1×759; 3×ZN; | ||||
| Assess | ||||||
| Peptide 4.2B in complex with BRD4.2 |
Heteromer O60885; | 1×ACE; 1×NH2; | ||||
| Assess | ||||||
| The PROTAC MZ1 in complex with the second bromodomain of Brd4 and pVHL:ElonginC:ElonginB |
Heteromer O60885; P40337; Q15369; Q15370; | 1×759; | ||||
| Assess | ||||||
| Crystal structure of macrocyclic PROTAC 1 in complex with the second bromodomain of human Brd4 and … |
Heteromer O60885; P40337; Q15369; Q15370; | 1×LFE; | ||||
| Assess | ||||||
| Ubiquitin ligation to neosubstrate by a cullin-RING E3 ligase & Cdc34: NEDD8-CUL2-RBX1-ELOB/C-VHL-M… |
Heteromer O60885; P0CG48; P40337; P62877; Q13617; Q15369; Q15370; Q712K3; | 3×ZN; 1×SY8; 1×759; | ||||
| Assess | ||||||
| (NEDD8)-CRL2VHL-MZ1-Brd4BD2-Ub(G76S, K48C)-UBE2R1(C93K, S138C, C191S, C223S)-Ub |
Heteromer L7N190; O60885; P0CG48; P40337; P49427; Q13617; Q15370; Q15843; | 1×759; 3×ZN; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF AT7 IN COMPLEX WITH THE SECOND BROMODOMAIN OF HUMAN BRD4 AND PVHL:ELONGINC:ELO… |
Heteromer O60885; P40337; Q15369; Q15370; | 1×IZR; | ||||
| Assess | ||||||
| Brd4 Bromodomain 2 in Complex with Acetylated Rel Peptide |
Heteromer O60885; Q04206; | 1×DTT; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a diacetylated histone 4 p… |
Heteromer O60885; P62805; | |||||
| Assess | ||||||
| Ternary complex between VCB, BRD4-BD2 and PROTAC 48 |
Heteromer O60885; P40337; Q15369; Q15370; | 1×QIY; | ||||
| Assess | ||||||
| DNA-encoded library (DEL)-enabled discovery of proximity inducing small molecules |
Heteromer O60885; P40337; Q15369; Q15370; | 1×X5K; | ||||
| Assess | ||||||
| Ternary complex between VCB, BRD4-BD2 and PROTAC 51 |
Heteromer O60885; P40337; Q15369; Q15370; | 1×QLX; | ||||
| Assess | ||||||
| Crystal Structure of BRD4-Brmo2 in complex with H2A.ZK4acK7ac peptide |
Heteromer O60885; P0C0S5; | |||||
| Assess | ||||||
| Cryo-EM structure of DDB1deltaB-DDA1-DCAF16-BRD4(BD2)-MMH2 |
Heteromer O60885; Q16531; Q9BW61; Q9NXF7; | 1×ZN; 1×YK3; | ||||
| Assess | ||||||
| Solution NMR structures of BRD4 ET domain in complex with NSD3_3 peptide |
Heteromer O60885; Q9BZ95; | |||||
| Assess | ||||||
| Solution NMR structures of BRD4 ET domain with JMJD6 peptide |
Heteromer O60885; Q6NYC1; | |||||
| Assess | ||||||
| Solution NMR structures of BRD4 ET domain with LANA peptide |
Heteromer O60885; Q9QR71; | |||||
| Assess | ||||||
| Solution NMR structures of BRD4 ET domain in complex with NSD3_1 peptide |
Heteromer O60885; Q9BZ95; | |||||
| Assess | ||||||
| Human Brd4 ET domain in complex with MLV Integrase C-term |
Heteromer O60885; Q8UN00; | |||||
| Assess | ||||||
| Crystal Structure of the Papillomavirus DNA Tethering Complex E2:Brd4 |
Heteromer O60885; P03120; | |||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor 21 | homo-3-mer | 3×XHE; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor 22 | homo-3-mer | 3×XHN; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor 23 | homo-3-mer | 3×XGN; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of human Bromodomain-containing protein 4 (BRD4) bromodomain with MS645 | homo-2-mer | 8×EDO; 1×CF6; | ||||
| Assess | ||||||
| BRD4-BD1 in complex with the cyclic peptide 3.1_2_AcK5toA | homo-2-mer | 1×NH2; | ||||
| Assess | ||||||
| BRD4-BD2 in complex with the cyclic peptide 3.1_2_AcK7toA | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 in complex with bivalent inhibitor G… | homo-2-mer | 4×EDO; 1×XR4; | ||||
| Assess | ||||||
| The first BET bromodomain of BRD4 bound to compound 13 in a bivalent manner | homo-2-mer | 1×XNH; 3×GOL; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 bound to GXH-II-052 | homo-2-mer | 1×ZMS; 2×EDO; | ||||
| Assess | ||||||
| BRD4-BD1 in complex with the cyclic peptide 3.1_2 | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 bound to GXH-II-082 | homo-2-mer | 1×ZMV; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 bound to GXH-II-075 | homo-2-mer | 3×EDO; 1×ZN1; | ||||
| Assess | ||||||
| Crystal Structure Analysis of the BRD4 | homo-2-mer | 2×H8C; | ||||
| Assess | ||||||
| BRD4-BD1 in complex with the cyclic peptide 4.2_1 | homo-2-mer | 4×IOD; 1×B3P; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 (BRD4-1) in complex with bivalent in… | homo-2-mer | 1×XR7; 7×EDO; 4×CL; 1×PEG; | ||||
| Assess | ||||||
| BRD4 first bromodomain (BD1) in complex with dual PI3 kinase inhibitor SF2523 | monomer | 1×82V; 1×PEG; 1×SCN; | ||||
| Assess | ||||||
| BRD4 Bromodomain 1 in complex with multi-action inhibitor SRX3212P | monomer | 1×ZVP; | ||||
| Assess | ||||||
| BRD4 first bromodomain (BD1) in complex with dual PI3 kinase (PI3K) inhibitor SF2535 | monomer | 1×837; | ||||
| Assess | ||||||
| BRD4 Bromodomain 1 in complex with triple CDK4/6-PI3K-BET inhibitor | monomer | 1×YR0; | ||||
| Assess | ||||||
| BRD4 first bromodomain (BD1) in complex with dual PI3 kinase (PI3K) inhibitor SF2558HA | monomer | 1×82Y; | ||||
| Assess | ||||||
| BRD4(BD1) complexed with 3219 | monomer | 1×FP7; 7×EDO; 1×DMS; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 5-(5-aminopyridin-3-yl)-8-(((3R,4R)-3-((1,1-dioxidotetrah… | monomer | 3×EDO; 1×6XW; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a 3,5-dimethylisoxazol lig… | monomer | 1×EDO; 1×E5T; | ||||
| Assess | ||||||
| BRD4 (BD1) in complex with APSC-derived ligands (e.g. LY294002) | monomer | 1×EDO; 1×LY2; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH LY303511 | monomer | 1×8DQ; 1×EDO; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a 3,5-dimethylisoxazol lig… | monomer | 1×E5W; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a 3,5-dimethylisoxazol lig… | monomer | 2×EDO; 1×E5Q; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a benzo-triazepine ligand … | monomer | 1×EDO; 1×08K; | ||||
| Assess | ||||||
| First bromodomain of BRD4 bound to inhibitor XD35 | monomer | 1×57F; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH LY294002 | monomer | 1×GOL; 1×LY2; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a quinazolin ligand | monomer | 1×13F; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with Alprazolam | monomer | 1×08H; 4×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor JQ1 | monomer | 1×JQ1; 1×IOD; 3×EDO; 1×DMS; | ||||
| Assess | ||||||
| BRD4 (BD1) in complex with docking-derived ligand | monomer | 1×EDO; 1×EGH; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a quinazolin ligand | monomer | 1×14X; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 4-chloro-2-methyl-5-(methylamino)pyridazin-3(2H)-one | monomer | 1×82I; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a quinazolin ligand | monomer | 2×EDO; 1×15E; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a quinazoline ligand | monomer | 1×EDO; 1×14Z; 1×K; | ||||
| Assess | ||||||
| BRD4-BD1 in complex with Cpd19 (3-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquino… | monomer | 1×EDO; 1×9U4; | ||||
| Assess | ||||||
| First bromodomain of BRD4 bound to inhibitor XD28 | monomer | 1×L28; 1×EDO; 1×BU3; 1×NA; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a 2-amine-9H-purine ligand | monomer | 1×EDO; 1×43U; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 8-(((3R,4R,5S)-3-((4,4-difluorocyclohexyl)methoxy)-5-meth… | monomer | 1×EDO; 1×6XX; | ||||
| Assess | ||||||
| BRD4 (BD1) in complex with APSC-derived ligands (e.g. SSLH01 a sulfasalazine derivate) | monomer | 1×EDO; 1×DMS; 1×EGE; | ||||
| Assess | ||||||
| First bromodomain of BRD4 bound to inhibitor XD47 | monomer | 1×56Y; 1×NA; 1×EDO; | ||||
| Assess | ||||||
| First bromodomain of BRD4 bound to inhibitor XD41 | monomer | 1×57E; 1×NI; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a 2-amine-9H-purine ligand | monomer | 1×43S; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 bound to CPI-0610 | monomer | 1×62G; | ||||
| Assess | ||||||
| First bromodomain of BRD4 bound to inhibitor XD42 | monomer | 1×57C; | ||||
| Assess | ||||||
| Structure of BRD4 bromodomain 1 with a dimethyl thiophene isoxazole azepine carboxamide | monomer | 1×1XB; | ||||
| Assess | ||||||
| BRD4 Bromodomain 1 in complex with multi-action inhibitor SRX3212 | monomer | 1×KV9; | ||||
| Assess | ||||||
| BRD4 bromodomain in complex with Cpd59 ((S)-1-(3-((2-fluoro-4-(1-methyl-1H-pyrazol-4-yl)phenyl)amin… | monomer | 6×EDO; 2×DMS; 1×GOL; 1×PEG; 1×6XH; | ||||
| Assess | ||||||
| BRD4-BD1 complexed with NEO2734 | monomer | 1×7OW; | ||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 with N-methylpyrrolidin-2-one (NMP) derivative 10 (methyl [… | monomer | 1×OWA; | ||||
| Assess | ||||||
| Crystal structure of the Bromo domain 1 in human Bromodomain Containing Protein 4 (BRD4) | monomer | 3×EDO; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 1,3-dimethyl-2-oxo-2,3- dihydro-1H-1,3-benzodiazole-5-car… | monomer | 1×DMS; 1×EDO; 1×V1T; | ||||
| Assess | ||||||
| BRD4 in complex with Cpd4 ((E)-3-(6-(but-2-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl… | monomer | 1×PGE; 2×EDO; 1×DMS; 1×69G; 1×GOL; | ||||
| Assess | ||||||
| BRD4 in complex with Cpd2 (N,N-dimethyl-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl… | monomer | 1×67B; 2×EDO; 1×DMS; | ||||
| Assess | ||||||
| Crystal structure of BRD4-BD1 bound with hjp126 | monomer | 1×8XR; | ||||
| Assess | ||||||
| Crystal structure of human BRD4(1) in complex with 4-[(2E)-3-(4-methoxyphenyl)-2-phenylprop-2-enoyl… | monomer | 1×Y80; | ||||
| Assess | ||||||
| First bromodomain of BRD4 bound to inhibitor XD26 | monomer | 1×L26; 4×EDO; | ||||
| Assess | ||||||
| First bromodomain of BRD4 bound to inhibitor XD33 | monomer | 1×L33; | ||||
| Assess | ||||||
| BRD4-BD1 in complex with the cyclic peptide 3.1_3 | monomer | |||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with Midazolam | monomer | 1×08J; | ||||
| Assess | ||||||
| BRD4(BD1) complexed with 2759 | monomer | 1×FOY; 2×EDO; | ||||
| Assess | ||||||
| Crystal structure of human BRD4(1) in complex with CN210 (compound 19) | monomer | 1×JBS; 1×GOL; | ||||
| Assess | ||||||
| First bromodomain of BRD4 bound to inhibitor XD40 | monomer | 1×L40; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with Olinone | monomer | 1×30M; 1×EDO; | ||||
| Assess | ||||||
| FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR #17 | monomer | 1×DZH; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the BRD4a/DB-2-190 complex | monomer | 1×4MW; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of BRD4 in complex with RT56 | monomer | 2×EDO; 1×H7E; | ||||
| Assess | ||||||
| BRD4 in complex with FragLite10 | monomer | 1×GOL; 1×1P8; | ||||
| Assess | ||||||
| First domain of human bromodomain BRD4 in complex with inhibitor 8-(5-Amino-1H-[1,2,4]triazol-3-yls… | monomer | 1×EDO; 1×5NV; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with SJ001010551-2 | monomer | 1×EDO; 1×5ZQ; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 with benzotriazolo-diazepine scaffold | monomer | 1×559; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BRD4-BD1 WITH COMPOUND 4 | monomer | 1×O1W; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with the dual inhibitor TW12 | monomer | 3×EDO; 1×P8Q; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX with compound F1 | monomer | 1×QGN; 2×EDO; | ||||
| Assess | ||||||
| BRD4 in complex with PepLite-Val | monomer | 2×GOL; 1×IT8; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of BRD4 in complex with a benzodiazepine ligand | monomer | 3×EDO; 1×KSZ; | ||||
| Assess | ||||||
| BRD4 in complex with FragLite19 | monomer | 3×GOL; 1×3Z7; | ||||
| Assess | ||||||
| Crystal Structure of BRD4-BD1 with BI894999 | monomer | 1×ZHO; 2×EDO; 1×DMS; | ||||
| Assess | ||||||
| X-ray crystal structure of human BRD4(BD1) in complex with RVX297 to 1.12 A resolution | monomer | 1×5GD; 4×EDO; | ||||
| Assess | ||||||
| BRD4 in complex with FragLite24 | monomer | 1×GOL; 2×IT4; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX with compound F5 | monomer | 3×EDO; 1×QGQ; | ||||
| Assess | ||||||
| BRD4 in complex with FragLite22 | monomer | 1×UUG; 1×GOL; | ||||
| Assess | ||||||
| A multiconformer ligand model of inhibitor 53W bound to CREB binding protein bromodomain | monomer | 1×53W; | ||||
| Assess | ||||||
| Selective pharmacological inhibition of the CREB binding protein bromodomain regulates inflammatory… | monomer | 1×53W; | ||||
| Assess | ||||||
| BRD4 in complex with PepLite-Gly | monomer | 1×ISK; 8×GOL; | ||||
| Assess | ||||||
| Bromodomain-containing protein 4 (BRD4) bromodomain 1 (BD1) complexed with YF3-126 | monomer | 1×YF6; 1×NA; | ||||
| Assess | ||||||
| BRD4 in complex with PepLite-Tyr | monomer | 1×T9J; 1×GOL; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH compound 3ag | monomer | 1×5Z4; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor XMD11-50 | monomer | 1×4K4; 2×EDO; | ||||
| Assess | ||||||
| BRD4 in complex with Acetyl-Lys | monomer | 3×GOL; 1×8WS; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with SJ001011461-1 | monomer | 1×EDO; 1×5Z0; | ||||
| Assess | ||||||
| N-terminal bromodomain of BRD4 in complex with OTX-015 | monomer | 3×EDO; 1×6JF; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 bound to NC-II-153 | monomer | 1×ZMM; 3×EDO; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 7-(3,4-dimethoxyphenyl)-2-(4-methanesulfonylpiperazine-1-… | monomer | 2×EDO; 1×N1D; | ||||
| Assess | ||||||
| FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR F1 | monomer | 1×DYZ; 4×EDO; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX with compound SSR4 | monomer | 3×EDO; 1×QHE; | ||||
| Assess | ||||||
| X-ray crystal structure of human BRD4(D1) in complex with 2-(4-{5-[6-(3,5-dimethylphenoxy)pyridin-2… | monomer | 5×EDO; 1×ZHS; 1×NA; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of BRD4 in complex with RT53 | monomer | 3×EDO; 1×H7B; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 bound to NC-III-53 | monomer | 1×N49; | ||||
| Assess | ||||||
| Bromodomain-containing protein 4 (BRD4) bromodomain 1 (BD1) complexed with ZN1-99 | monomer | 1×VCV; | ||||
| Assess | ||||||
| Bromodomain-containing protein 4 (BRD4) bromodomain 1 (BD1) complexed with YF3-6 | monomer | 1×Y36; | ||||
| Assess | ||||||
| Discovery of benzotriazolo diazepines as orally-active inhibitors of BET bromodomains: Crystal stru… | monomer | 1×FMT; 1×3X0; | ||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 with N-methylpyrrolidin-2-one (NMP) derivative 17 (5-{2-[(3… | monomer | 1×Y17; | ||||
| Assess | ||||||
| Bromodomain-containing 4 BD1 in complex with the inhibitor CRCM5484 | monomer | 1×8M6; | ||||
| Assess | ||||||
| BRD4 in complex with FragLite21 | monomer | 2×UUJ; 1×GOL; | ||||
| Assess | ||||||
| X-ray crystal structure of bromodomain complex to 1.24 A resolution | monomer | 1×1K0; 2×EDO; 1×NA; | ||||
| Assess | ||||||
| BRD4 in complex with FragLite32 | monomer | 1×GOL; 1×IS0; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with the dual inhibitor TW22 | monomer | 3×EDO; 1×P8N; | ||||
| Assess | ||||||
| N-terminal bromodomain of BRD4 in complex with OTX-015 | monomer | 1×6JE; | ||||
| Assess | ||||||
| BRD4 in complex with FragLite33 | monomer | 1×HWC; 3×GOL; | ||||
| Assess | ||||||
| X-ray crystal structure of 18a in BRD4(1) | monomer | 1×VFI; | ||||
| Assess | ||||||
| Structure of BRD4 bromodomain 1 with a 3-methyl-4-phenylisoxazol-5-amine fragment | monomer | 2×FMT; 1×1XA; | ||||
| Assess | ||||||
| BRD4 in complex with PepLite-Pro | monomer | 1×IS6; 3×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with compound B13 | monomer | 1×EDO; 1×2N0; | ||||
| Assess | ||||||
| Crystal structure of human BRD4(1) bromodomain in complex with JRMBR4106 | monomer | 1×9OE; 1×EDO; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH N-(1,1-dioxo-1-thian-4-yl)- 5-methyl-4-oxo-7-3-(trifluoro… | monomer | 3×EDO; 1×5V2; | ||||
| Assess | ||||||
| Crystal Structure of apo-BRD4(1) | monomer | 10×EDO; 1×IOD; 1×NA; 1×21H; | ||||
| Assess | ||||||
| Cocrystal of BRD4(D1) with a ethyl carbamate thiazepane inhibitor | monomer | 1×EDO; 1×QKD; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH compound 3bg | monomer | 1×5YY; | ||||
| Assess | ||||||
| X-ray crystal structure of human BRD4(D1) in complex with 2-(4-{5-[6-(2,5-dibromophenoxy)pyridin-2-… | monomer | 1×EDO; 1×ZHV; 2×CL; | ||||
| Assess | ||||||
| Crystal structure of human BRD4(1) in complex with 4-[(5-phenylpyridin-3-yl)carbonyl]-3,4-dihydroqu… | monomer | 1×Y81; 1×GOL; 1×NA; | ||||
| Assess | ||||||
| Crystal structure of the human BRD4-BD1 bromodomain in complex with the inhibitor CRCM5464 | monomer | 1×Q2F; 2×EDO; 1×DMS; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with GW612286X | monomer | 1×SAV; 5×EDO; 1×PGE; 1×CL; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with SB-409514 | monomer | 1×2RF; 4×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with SG3-014 | monomer | 1×5VZ; 1×PEG; 3×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with MA4-022-2 | monomer | 1×5W1; 6×EDO; | ||||
| Assess | ||||||
| Bromodomain-containing protein 4 (BRD4) bromodomain 1 (BD1) complexed with XR844 | monomer | 1×7QZ; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of BRD4 in complex with AYC | monomer | 5×5J5; 1×DMS; | ||||
| Assess | ||||||
| NN-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 5-5-methoxypyridin-3-yl-3- methyl-8-piperidin-4-ylamino-… | monomer | 1×EDO; 1×NP8; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with FLAVOPIRIDOL | monomer | 1×CPB; 3×EDO; | ||||
| Assess | ||||||
| BRD4 in complex with PepLite-Ala | monomer | 1×GOL; 1×IJR; | ||||
| Assess | ||||||
| Cocrystal of BRD4(D1) with a methyl carbamate thiazepane inhibitor | monomer | 3×EDO; 1×DMS; 1×QJ1; | ||||
| Assess | ||||||
| N-terminal domain of BRD4 with biphenyl-methyamino-dimethylpyridazinone | monomer | 1×P8W; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 bound to benzoisoxazoloazepine 3 | monomer | 1×62V; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH I-BET295 | monomer | 1×EDO; 1×IES; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 bound to bromosporine | monomer | 1×BMF; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with TG101348 | monomer | 1×2TA; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of BRD4(1) bound to inhibitor BUG0 (6) | monomer | 1×KLK; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with NU7441 | monomer | 1×2R4; 1×PEG; 5×EDO; 3×CL; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with MS417 inhibitor | monomer | 2×EDO; 1×0S6; | ||||
| Assess | ||||||
| Crystal Structure of BRD4(1) bound to inhibitor BUX2 (9) | monomer | 1×KXK; 4×BU3; | ||||
| Assess | ||||||
| The first bromodomain of human BRD4 in complex with 3,5 dimethylisoxaxole ligand | monomer | 3×EDO; 1×S5B; | ||||
| Assess | ||||||
| N-terminal bromodomain of BRD4 in complex with PLX5981 | monomer | 1×EDO; 1×6JC; | ||||
| Assess | ||||||
| Crystal structure of BRD4 in complex with DMSO (Cocktail No. 4) | monomer | 3×NA; 1×DMS; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH GSK620 | monomer | 2×EDO; 1×1PE; 1×QCZ; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 3-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)-N-(3-methyl-[1,2,4… | monomer | 1×R5W; 3×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with BI 2536 | monomer | 1×R78; 2×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human 3-fluoro tyrosine-labeled brd4 in complex with … | monomer | 1×JQ1; 2×EDO; 1×CL; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with SG3-179 | monomer | 1×5W2; 2×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with MA4-022-1 | monomer | 2×EDO; 1×5W0; | ||||
| Assess | ||||||
| First bromodomain of BRD4 liganded with BMS-536924 | monomer | 1×N6I; 5×EDO; | ||||
| Assess | ||||||
| Crystal structure of BRD4 in complex with isoliquiritigenin and DMSO (Cocktail No. 3) | monomer | 3×NA; 1×HCC; 1×DMS; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BRD4-BD1 WITH COMPOUND 3 | monomer | 1×O2B; | ||||
| Assess | ||||||
| BRD4-D1 in complex with BET inhibitor | monomer | 1×U59; 1×EDO; | ||||
| Assess | ||||||
| BRD4-D1 in complex with BET inhibitor | monomer | 1×UHI; 1×EDO; | ||||
| Assess | ||||||
| BRD4 bromodomain 1 in complex with HYB157 | monomer | 1×GUJ; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor JWG056 | monomer | 1×X27; | ||||
| Assess | ||||||
| BRD4-D1 in complex with BET inhibitor | monomer | 1×U7R; 1×EDO; | ||||
| Assess | ||||||
| BRD4 (BD1) in complex with APSC-derived ligands (e.g. sulfasalazine) | monomer | 1×EDO; 1×FMT; 1×DMS; 1×SAS; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 1-((1-acetylpiperidin-4-yl)methyl)-2-(4-hydroxy-3,5-dimet… | monomer | 1×NUW; 3×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of BRD4 in complex with a BzD ligand | monomer | 1×RGW; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with the ligand ZZ001229a | monomer | 1×EDO; 1×IX4; | ||||
| Assess | ||||||
| Bivalent binding to BET bromodomains | monomer | |||||
| Assess | ||||||
| Crystal structure of the human BRD4-BD1 bromodomain in complex with the inhibitor CRCM5483 | monomer | 1×Q2F; 3×EDO; 1×DMS; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A DIHYDROPYRIDOPYRIMIDINE … | monomer | 1×6RX; 1×EDO; 2×SO4; | ||||
| Assess | ||||||
| Crystal structure of human BRD4(1) bromodomain in complex with UT22B | monomer | 1×B0Q; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of BRD4 in complex with DMA | monomer | 1×5Y9; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with I-BET151(GSK1210151A) | monomer | 4×EDO; 1×1GH; | ||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 with N-methylpyrrolidin-2-one (NMP) derivative 5 (1-methyl-… | monomer | 1×RLG; | ||||
| Assess | ||||||
| The first bromodomain of human BRD4 in complex with 3,5 dimethylisoxaxole ligand | monomer | 3×EDO; 1×9BM; | ||||
| Assess | ||||||
| Crystal Structure of BRD4(1) bound to inhibitor BUX6 (12) | monomer | 3×BU3; 1×L2Z; | ||||
| Assess | ||||||
| Crystal structure of BRD4(1) bound to the dual BET-HDAC inhibitor LSH24 | monomer | 2×S7T; | ||||
| Assess | ||||||
| A multiconformer ligand model of 3,5 dimethylisoxaxole bound to the bromodomain of human BRD4 | monomer | 3×EDO; 1×9BM; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with SB-284847-BT | monomer | 1×2RJ; 3×EDO; | ||||
| Assess | ||||||
| Crystal Structure of BRD4(1) bound to inhibitor BUX14 (7) | monomer | 1×L45; 1×BU3; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 bound to XMD8-92 | monomer | 1×4WG; | ||||
| Assess | ||||||
| Crystal Structure of BRD4(1) bound to inhibitor BUX5 (11) | monomer | 1×L2W; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of BRD4 in complex with 18-Crown-6 | monomer | 1×LOC; 1×O4B; 1×NA; | ||||
| Assess | ||||||
| Crystal Structure of BRD4(1) bound to inhibitor BUX3 (10) | monomer | 2×BU3; 1×L25; | ||||
| Assess | ||||||
| Crystal structure of BRD4 first bromodomain in complex with SGC-CBP30 chemical probe | monomer | 1×2LO; 1×EDO; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH DB-1-264-2 | monomer | 1×6TB; 7×EDO; | ||||
| Assess | ||||||
| Cocrystal of BRD4(D1) with a methyl carbamate thiazepane inhibitor | monomer | 1×QJA; 1×EDO; | ||||
| Assess | ||||||
| Bromodomain-containing protein 4 (BRD4) bromodomain 1 (BD1) complexed with compound 27 | monomer | 2×GOL; 1×YF2; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with a tetrahydroquinoline anal… | monomer | 1×8J2; 2×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with FOSTAMATINIB | monomer | 1×2RC; 2×EDO; | ||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 with N-methylpyrrolidin-2-one (NMP) derivative 7b (1-methyl… | monomer | 1×RLS; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 in complex with dual BRD4-JAK2 inhib… | monomer | 1×EDO; 1×4OW; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with DINACICLIB | monomer | 2×1QK; 3×EDO; | ||||
| Assess | ||||||
| Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibi… | monomer | 1×L5S; 2×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with SB-614067-R | monomer | 1×2RK; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a novel inhibitor UMB32 (N… | monomer | 1×3P2; 2×EDO; 2×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a triazolo-phthalazine lig… | monomer | 1×Y1Z; 1×SIN; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 7-(3,4-dimethoxyphenyl)-N-(1,1-dioxo-1-thian-4-yl)-5-meth… | monomer | 1×CA; 1×EDO; 1×TVU; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH N-(2-(1H-imidazol-4-yl)ethyl)-4-acetamido-3-(benzyloxy)be… | monomer | 1×QB5; | ||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 with N-methylpyrrolidin-2-one (NMP) derivative 7h (4-(1-met… | monomer | 1×RLV; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH GSK1324726A (I-BET726) | monomer | 1×73B; | ||||
| Assess | ||||||
| FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR 3-(4-Chlorobenzyl)-7-ethyl-3,7-dih… | monomer | 1×5OU; 2×EDO; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH IBET-295 | monomer | 1×EDO; 1×83T; | ||||
| Assess | ||||||
| Crystal structure of fragment bound with Brd4 | monomer | 1×64Q; | ||||
| Assess | ||||||
| Crystal Structure of BRD4(1) bound to inhibitor BUX1 (8) | monomer | 1×BU3; 1×KUH; 1×CA; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a isoxazolylbenzimidazole … | monomer | 1×0Q1; 2×EDO; 1×NA; | ||||
| Assess | ||||||
| Crystal structure of BRD4 in complex with 2',4'-dihydroxy-2-methoxychalcone | monomer | 1×A0R; 2×NA; | ||||
| Assess | ||||||
| Crystal Structure of the First Bromodomain of Human Brd4 in complex with IBET inhibitor | monomer | 1×EAM; 4×EDO; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH HU-10, A 1,4,5-Trisubstitu… | monomer | 1×JQP; 2×EDO; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH iBET-BD2 (GSK046) | monomer | 3×EDO; 1×LW5; | ||||
| Assess | ||||||
| Structure of the first bromodomain of BRD4 with a pyrazolo[4,3-c]pyridin fragment | monomer | 2×EDO; 1×77X; | ||||
| Assess | ||||||
| BRD4 (BD1) in complex with APSC-derived ligands | monomer | 1×EGN; 2×FMT; 2×NA; 1×GOL; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH INHIBITOR 8841871 | monomer | 1×7CM; 4×EDO; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 4-chloro-2-methyl-5-(((3-methylthiophen-2-yl)methyl)amino… | monomer | 1×RNK; 3×GOL; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 with GSK789 | monomer | 1×QAN; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 in complex with dual BRD4-JAK2 inhib… | monomer | 2×EDO; 1×UY0; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH INHIBITOR 17528462 | monomer | 1×7CQ; 4×EDO; | ||||
| Assess | ||||||
| Crystal structure of BRD4 BROMODOMAIN 1 IN COMPLEX WITH LIGAND 2 | monomer | 2×EDO; 1×7E7; | ||||
| Assess | ||||||
| Crystal Structure of the First Bromodomain of Human Brd4 with the inhibitor GW841819X | monomer | 1×EDO; 1×WSH; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor TG-101348 | monomer | 2×EDO; 1×2TA; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH INHIBITOR 7635936 | monomer | 1×7CJ; 3×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a quinazolinone ligand (RV… | monomer | 3×EDO; 1×1K0; | ||||
| Assess | ||||||
| The first bromodomain of human BRD4 in complex with 3,5 dimethylisoxaxole ligand | monomer | 1×9B6; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a quinazolinone ligand (RV… | monomer | 1×EDO; 1×1K0; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a 3,5-dimethylisoxazol lig… | monomer | 3×EDO; 1×ODR; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with bromosporine (BSP) | monomer | 1×EDO; 1×BMF; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 bound to ERK5-IN-1 | monomer | 3×VYJ; 2×EDO; | ||||
| Assess | ||||||
| FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR 4-[(1-methyl-2-oxo-1,2-dihydroquin… | monomer | 1×5D1; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with TG101209 | monomer | 1×1M3; 1×EDO; | ||||
| Assess | ||||||
| BRD4 Bromodomain 1 with an inhibitor | monomer | 1×99L; 1×DMS; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH INHIBITOR 17503468 | monomer | 4×EDO; 1×7CG; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH INHIBITOR 8841881 | monomer | 1×7CO; 3×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a 3,5-dimethylisoxazol lig… | monomer | 4×EDO; 1×1H2; 1×IOD; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a 2-methyl-quinoline ligand | monomer | 1×EDO; 1×25V; 1×DMS; | ||||
| Assess | ||||||
| Crystal Structure of BRD4 with QC4956 | monomer | 1×F5Y; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor BI-2536 | monomer | 1×EDO; 1×R78; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with SKT-68, a 1,4,5-trisubstit… | monomer | 1×JQY; 1×DMS; 2×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 bound to BI7273 | monomer | 1×5SW; 5×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with MA2-014 | monomer | 1×5VY; 2×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a 5-methyl-triazolopyrimid… | monomer | 1×EDO; 1×25O; | ||||
| Assess | ||||||
| Crystal structure of BRD4(1) in complex with the inhibitor MPM2 | monomer | 1×I5K; 1×BU3; 1×DMS; 1×P6G; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH Volasertib | monomer | 1×IBI; 1×EDO; 2×DMS; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with SB-251527 | monomer | 1×2RQ; 1×EDO; 1×CL; | ||||
| Assess | ||||||
| BRD4 Bromodomain 1 with an inhibitor | monomer | 1×99U; | ||||
| Assess | ||||||
| BRD4 Bromodomain 1 with an inhibitor | monomer | 1×99R; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 1,3-dimethyl-5-(1-((tetrahydro-2H-pyran-4-yl)methyl)-1H-b… | monomer | 3×EDO; 1×NUB; | ||||
| Assess | ||||||
| BRD4 in complex with 2-(2-(4-(3,5-dimethylisoxazol-4-yl)-1H-pyrazol-1-yl)acetamido)-N-ethylpropanam… | monomer | 1×SY0; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 in complex with dual BRD4-JAK2 inhib… | monomer | 1×4OF; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a 5-methyl-triazolopyrimid… | monomer | 1×EDO; 1×25K; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH RO3280 | monomer | 2×EDO; 1×PEG; 1×79C; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH INHIBITOR 8841880 | monomer | 1×7CN; 4×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a 3,5-dimethylisoxazol lig… | monomer | 4×EDO; 1×1H3; | ||||
| Assess | ||||||
| Crystal Structure Analysis of the BRD4 | monomer | 1×8Q3; 2×EDO; 2×NO3; 1×NA; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a 3-chloro-pyridone ligand | monomer | 1×24Y; | ||||
| Assess | ||||||
| Crystal Structure of BRD4(1) bound to Colchicine | monomer | 1×LOC; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with PNZ5 isoxazole inhibitor | monomer | 1×5W4; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH 2-(3,5-dimethyl-1,2-oxazol… | monomer | 1×YW7; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with SB-610251-B | monomer | 2×2RN; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of BRD4 in complex with isoliquiritigenin in the absence of DMSO | monomer | 1×HCC; 2×NA; | ||||
| Assess | ||||||
| The first bromodomain of human BRD4 in complex with 3,5 dimethylisoxaxole ligand | monomer | 1×EDO; 1×UTH; | ||||
| Assess | ||||||
| Crystal structure of BRD4(1) in complex with the inhibitor MPM6 | monomer | 1×SOK; 2×DMS; | ||||
| Assess | ||||||
| Crystal Structure of BRD4(1) bound to inhibitor XD14 | monomer | 1×21Q; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH (1R,1'R)-7,7'-(ethane-1,2-diylbis(oxy))bis(1,3-dimethyl-1… | monomer | 1×EDO; 1×ZTT; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with a dihydro-quinazolin ligand | monomer | 1×WDR; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with 5-((4-fluoro-1H-imidazol-1… | monomer | 1×9E3; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor ZL0516 | monomer | 5×EDO; 1×QKP; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with SB 202190 | monomer | 1×2RE; | ||||
| Assess | ||||||
| BRD4 Bromodomain 1 with an inhibitor | monomer | 1×99O; | ||||
| Assess | ||||||
| Bivalent binding to BET bromodomains | monomer | 1×ETU; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 1-(2R,4S)-2-methyl-4-(phenylamino)-6-4-(piperidin-1-ylmet… | monomer | 3×EDO; 1×9S3; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH 9-benzyl-2-(3,5-dimethyl-1… | monomer | 1×YW4; | ||||
| Assess | ||||||
| Crystal structure of BRD4 Bromodomain1 with an inhibitor | monomer | 1×D7U; | ||||
| Assess | ||||||
| Crystal Structure of BRD4(1) bound to inhibitor XD46 | monomer | 1×L46; | ||||
| Assess | ||||||
| BRD4 Bromodomain1 with an inhibitor | monomer | 1×D89; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH (1R,1'R)-7,7'-(pentane-1,5-diylbis(oxy))bis(1,3-dimethyl-… | monomer | 1×ZTY; | ||||
| Assess | ||||||
| BRD4 Bromodomain1 with an inhibitor | monomer | 1×D7X; | ||||
| Assess | ||||||
| BRD4 Bromodomain1 with an inhibitor | monomer | 1×D7R; | ||||
| Assess | ||||||
| Joint nentron and X-ray structure of BRD4 in complex with colchicin | monomer | 1×LOC; 1×NA; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 bound to NC-II-259 | monomer | 1×ZMJ; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 in complex with dual BRD4-JAK2 inhib… | monomer | 1×R6S; 3×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 bound to GXH-II-076 | monomer | 1×ZNJ; 2×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with the inhibitor 16i | monomer | 5×EDO; 1×HG5; | ||||
| Assess | ||||||
| BRD4 in complex with 259 | monomer | 1×C6X; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor JWG046 | monomer | 1×EX1; 3×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of BRD4 in complex with B16 | monomer | 1×2NJ; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of BRD4 in complex with N-methyltrimethylacetamide | monomer | 5×EDO; 1×BAE; 1×DMS; | ||||
| Assess | ||||||
| Crystal structure of human BRD4(1) in complex with CN750 | monomer | 1×HRY; 1×GOL; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 (3R,4R)-N-cyclohexyl-4-((3-methyl-2-oxo-1,2-dihydro-1,7-naphth… | monomer | 1×QAZ; | ||||
| Assess | ||||||
| X-ray crystal structure of human BRD4(D1) in complex with 2-(2,5-dibromophenoxy)-6-[4-methyl-1-(pip… | monomer | 1×ZHM; 2×EDO; 2×CL; | ||||
| Assess | ||||||
| Development of BRD4 inhibitors as arsenicals antidotes | monomer | 1×EM0; 3×GOL; | ||||
| Assess | ||||||
| BRD4-BD1 Compound6 (methyl 4-(3,5-difluoropyridin-2-yl)-10-methyl-7-((methylsulfonyl)methyl)-11-oxo… | monomer | 1×WEM; | ||||
| Assess | ||||||
| Bromodomain-containing 4 BD1 in complex with 3',4',7,8-Tetrahydroxyflavone | monomer | 1×SQH; 1×FMT; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH (S)-5-(1-((1-(1-isopropylpiperidine-4-carbonyl)piperidin-… | monomer | 1×I0Z; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with MS267 inhibitor | monomer | 1×NUE; 1×EDO; | ||||
| Assess | ||||||
| BRD4-BD1 in complex with LT-730-903 | monomer | 1×N03; | ||||
| Assess | ||||||
| Crystal structure of BRD4 BROMODOMAIN 1 IN COMPLEX WITH LIGAND 1 | monomer | 1×7EA; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with (+)-JD1, an Organometallic… | monomer | 2×EDO; 1×L8W; 2×DMS; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 bound to benzotriazolo-diazepine scaffold | monomer | 1×558; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of BRD4 in complex with DMSO | monomer | 4×EDO; 1×DMS; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with MS435 inhibitor | monomer | 1×435; 1×EDO; | ||||
| Assess | ||||||
| BRD4 in complex with 500 | monomer | 1×C89; | ||||
| Assess | ||||||
| Crystal Structure Analysis of the BRD4(1) | monomer | 1×EFN; 2×NO3; 2×EDO; 2×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor ZL0590 | monomer | 1×DMS; 1×POJ; | ||||
| Assess | ||||||
| Discovery of Selective BRD4 BD1 Inhibitor Based on [1,2,4] triazolo [4,3-b] pyridazine Scaffold | monomer | 1×97F; | ||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 with N-methylpyrrolidin-2-one (NMP) derivative 15c (N,N-die… | monomer | 1×NO3; 1×RLY; | ||||
| Assess | ||||||
| Brd4 Bromodomain 1 complex with 4-(2-FLUOROPHENYL)-1,3-THIAZOL-2(3H)-ONE inhibitor | monomer | 1×1A7; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of BRD4 in complex with pyrrolidin-2-one | monomer | 1×BAQ; 5×EDO; | ||||
| Assess | ||||||
| Crystal structure of human BRD4(1) bromodomain in complex with UT48 | monomer | 1×B0N; | ||||
| Assess | ||||||
| BRD4 in complex with ZZM1 | monomer | 1×BT0; | ||||
| Assess | ||||||
| BRD4-BD1 in complex with LT-448-138 | monomer | 1×YD8; | ||||
| Assess | ||||||
| Brd4 Bromodomain 1 complex with 3-CYCLOHEXYL-N-{3-(2-OXO-2,3-DIHYDRO-1,3-THIAZOL-4-YL)-5-[(THIOPHEN… | monomer | 1×1A9; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of BRD4 in complex with a benzo-diazepine ligand | monomer | 1×OS8; | ||||
| Assess | ||||||
| Brd4 Bromodomain 1 complex with N-[3-(2-OXO-2,3-DIHYDRO-1,3-THIAZOL-4-YL)PHENYL]THIOPHENE-2-SULFONA… | monomer | 1×1A4; | ||||
| Assess | ||||||
| Cocrystal of BRD4(D1) with a selective inhibitor | monomer | 4×EDO; 1×U0D; | ||||
| Assess | ||||||
| First bromodomain of BRD4 liganded with CCS-1477 | monomer | 1×JHL; 2×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with benzo[cd]indol-2(1H)-one l… | monomer | 1×GOL; 1×E0A; 3×EDO; | ||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 with N-methylpyrrolidin-2-one (NMP) derivative 18 (5-{[(3R)… | monomer | 1×Y18; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 1,3-DIMETHYL-6-(MORPHOLINE- 4-SULFONYL)-1,2,3,4-TETRAHYDR… | monomer | 3×EDO; 1×P9L; 2×NO3; | ||||
| Assess | ||||||
| Brd4 Bromodomain 1 complex with 6,7-DIHYDROTHIENO[3,2-C]PYRIDIN-5(4H)-YL(1H-IMIDAZOL-1-YL)METHANONE… | monomer | 1×1AJ; | ||||
| Assess | ||||||
| Crystal Structure of BRD4 with QC4956 | monomer | 1×F5V; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with benzo[cd]indol-2(1H)-one l… | monomer | 1×55K; | ||||
| Assess | ||||||
| BRD4-BD1 in complex with LT-642-602 | monomer | 1×J4O; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 with I-BET567 | monomer | 1×AKQ; 3×EDO; | ||||
| Assess | ||||||
| Benzopiperazine BET bromodomain inhibitor in complex with BD1 of Brd4 | monomer | 1×9GY; | ||||
| Assess | ||||||
| Crystal of BRD4(D1) with 2-[(3R)-3-{5-[2-(3,5-dimethylphenoxy)pyrimidin-4-yl]-4-(4-iodophenyl)-1H-i… | monomer | 1×7ZK; | ||||
| Assess | ||||||
| First bromodomain of BRD4 bound to inhibitor XD29 | monomer | 1×57G; | ||||
| Assess | ||||||
| BRD4-BD1 in complex with LT-909-110 | monomer | 1×909; | ||||
| Assess | ||||||
| RD4-BD1 in complex with LT-872-297 | monomer | 1×J4R; | ||||
| Assess | ||||||
| First bromodomain of BRD4 bound to inhibitor XD27 | monomer | 1×56M; 1×GOL; 1×BU3; | ||||
| Assess | ||||||
| BRD4 in complex with 138A | monomer | 1×BS6; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 8-(3R,4R)-3-(cyclohexylmethoxy)piperidin-4-ylamino-3-meth… | monomer | 1×EDO; 1×78J; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 bound to TP-472 | monomer | 1×QMG; 1×EDO; | ||||
| Assess | ||||||
| First bromodomain of BRD4 bound to inhibitor XD44 | monomer | 1×579; 1×DMS; 1×BU3; | ||||
| Assess | ||||||
| Brd4 Bromodomain 1 complex with 3-{[(3-METHYL-1,2-OXAZOL-5-YL)METHYL]SULFANYL}[1,2,4]TRIAZOLO[4,3-A… | monomer | 1×1A6; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH 2-{(7P)-7-(1,4-dimethyl-1H… | monomer | 1×YWY; | ||||
| Assess | ||||||
| Crystal Structure Analysis of the BRD4 | monomer | 1×E0K; 1×EDO; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor ZJ12 | monomer | 1×5E3; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of BRD4 first bromodomain in complex with ferulic acid | monomer | 2×EDO; 1×FER; | ||||
| Assess | ||||||
| Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibi… | monomer | 1×H4C; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH compound 5ef | monomer | 1×5Z1; | ||||
| Assess | ||||||
| Crystal structure of fragment bound with Brd4 | monomer | 1×64S; | ||||
| Assess | ||||||
| Crystal structure of human BRD4(1) bromodomain in complex with DR46 | monomer | 1×AY2; | ||||
| Assess | ||||||
| Crystal structure of BRD4-BD1 in complex with NVS-BET-1 | monomer | 1×QFN; | ||||
| Assess | ||||||
| Crystal Structure Analysis of the BRD4 | monomer | 1×8QC; 2×NO3; 1×GOL; 1×NA; | ||||
| Assess | ||||||
| FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR 3-Butyl-8-(6-butyl-5,7-dimethyl-[1… | monomer | 1×5NQ; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with benzo[cd]indol-2(1H)-one l… | monomer | 1×E0C; 1×EDO; 1×DMS; | ||||
| Assess | ||||||
| BRD4 Bromodomain 1 in complex with multi-action inhibitor SF2523P | monomer | 1×UT4; | ||||
| Assess | ||||||
| Crystal structure of human Bromodomain-containing protein 4 (BRD4) bromodomain with MS660 | monomer | 1×H1V; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with the dual inhibitor TW9 | monomer | 2×EDO; 1×P8T; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BRD4-BD1 WITH COMPOUND 1 | monomer | 2×EDO; 1×O32; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with the dual BET/HDAC inhibito… | monomer | 1×X9K; 3×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with the dual BET/HDAC inhibito… | monomer | 1×X9C; 5×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with MS436 inhibitor | monomer | 1×NUD; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with the dual BET/HDAC inhibito… | monomer | 6×EDO; 1×X9U; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH iBET-BD1 (GSK778) | monomer | 1×GLU; 1×LWB; 1×EDO; | ||||
| Assess | ||||||
| Brd4 Bromodomain 1 complex with its novel inhibitors | monomer | 1×BNK; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with the dual BET/HDAC inhibito… | monomer | 1×XA3; 4×EDO; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 5-(1-(1,3-dimethoxypropan-2-yl)-5-morpholino-1H-benzo[d]i… | monomer | 2×EDO; 1×NV2; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with the dual BET/HDAC inhibito… | monomer | 1×X9O; 5×EDO; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH LRRK2-IN-1 | monomer | 1×4K4; 2×CL; 5×EDO; | ||||
| Assess | ||||||
| Direct photocapture of bromodomains using tropolone chemical probes | monomer | 1×3OT; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 (BD1) in complex with 4-ethoxy-5,16-dimethoxy-11-methyl-2-o… | monomer | 1×D9C; 4×FMT; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor JWG048 | monomer | 1×X30; 1×EDO; | ||||
| Assess | ||||||
| Brd4 Bromodomain 1 complex with its novel inhibitors | monomer | 1×BNJ; | ||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 (BD1) in complex with 2-({3-ethyl-[1,2,4]triazolo[4,3-b]pyr… | monomer | 1×NA; 1×JHO; 2×FMT; 1×GOL; | ||||
| Assess | ||||||
| Bromodomain and Extra-terminal Domain (BET) BRD4 | monomer | 1×WPR; | ||||
| Assess | ||||||
| Crystal Structure of BRD4(D1) with 4-[4-(4-bromophenyl)-1-(piperidin-4-yl)-1H-imidazol-5-yl]-N-(3,5… | monomer | 1×EDO; 1×7ZB; | ||||
| Assess | ||||||
| Brd4 Bromodomain 1 complex with its novel inhibitors | monomer | 1×BNM; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with the dual BET/HDAC inhibito… | monomer | 1×X8O; 7×EDO; | ||||
| Assess | ||||||
| Crystal Structure Analysis of the BRD4 | monomer | 2×NO3; 1×8P9; 2×EDO; 1×GOL; | ||||
| Assess | ||||||
| Crystal of BRD4(D1) with 2-[(3S)-3-{5-[2-(3,5-dimethylphenoxy)pyrimidin-4-yl]-4-(4-iodophenyl)-1H-i… | monomer | 1×EDO; 1×7ZT; | ||||
| Assess | ||||||
| Brd4 Bromodomain 1 complex with N-[3-(2-OXO-2,3-DIHYDRO-1,3-THIAZOL-4-YL)PHENYL]-1-PHENYLMETHANESUL… | monomer | 1×1A3; | ||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 (BD1) in complex with STL233497 | monomer | 4×FMT; 2×NA; 2×GOL; 1×KCL; | ||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 (BD1) in complex with 16-methoxy-11-methyl-6-[(pyridin-2-yl… | monomer | 1×D6U; 2×FMT; | ||||
| Assess | ||||||
| BRD4 bound with compound Bdi4 | monomer | 1×8F0; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with benzo[cd]indol-2(1H)-one l… | monomer | 3×NO3; 2×EDO; 1×E0B; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 (BD1) in complex with N-[2-(1H-indol-3-yl)ethyl]-3-(trifluo… | monomer | 1×CL; 1×JLX; 2×FMT; | ||||
| Assess | ||||||
| Brd4 Bromodomain 1 complex with N-{3-(2-OXO-2,3-DIHYDRO-1,3-THIAZOL-4-YL)-5-[(THIOPHEN-2-YLSULFONYL… | monomer | 1×1A8; | ||||
| Assess | ||||||
| Crystal structure of BRD4-BD1 bound with hjp64 | monomer | 1×8XX; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor JWG047 | monomer | 1×X26; 3×EDO; 1×NO3; | ||||
| Assess | ||||||
| Brd4 Bromodomain 1 complex with a fragment 3,4-Dihydro-3-methyl-2(1H)-quinazolinon | monomer | 1×3PF; | ||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 (BD1) in complex with C239-0012 | monomer | 2×FMT; 1×NA; 1×KC3; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor JWG071 | monomer | 1×F2S; 1×FND; 3×EDO; 2×NO3; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 with benzodiazepine inhibitor | monomer | 1×UDV; | ||||
| Assess | ||||||
| First bromodomain of BRD4 liganded with compound 2c | monomer | 1×OFR; 2×EDO; | ||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 (BD1) in complex with 6,16-dimethoxy-11-methyl-2-oxa-11-aza… | monomer | 4×FMT; 1×D6R; | ||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 (BD1) in complex with 6-hydroxy-16-methoxy-11-methyl-2-oxa-… | monomer | 7×FMT; 1×D7L; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor XMD17-26 | monomer | 1×R4L; 3×EDO; 1×NO3; | ||||
| Assess | ||||||
| crystal structure of the first bromodomain of human BRD4 in complex with compound BDF-2138 | monomer | 1×ECR; | ||||
| Assess | ||||||
| Trimethoxy-ring inhibitor in complex with the first bromodomain of BRD4 | monomer | 1×RMR; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with benzo[cd]indol-2(1H)-one l… | monomer | 1×EB3; | ||||
| Assess | ||||||
| brd4-bd1 bound with ligand 138 | monomer | 1×BOF; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with benzo[cd]indol-2(1H)-one l… | monomer | 2×EDO; 1×EB2; | ||||
| Assess | ||||||
| Crystal Structure Analysis of the BRD4 | monomer | 1×EFL; 3×EDO; 1×GOL; 1×NO3; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor Y07004 | monomer | 1×JCO; 1×GOL; 1×NO3; | ||||
| Assess | ||||||
| BRD4 BD1 bound with compound 10 | monomer | 1×EDF; | ||||
| Assess | ||||||
| The first bromodomain of BRD4 with compound BDF-2254 | monomer | 1×96U; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with an isoxazolyl-benzimidazol… | monomer | 1×K; 1×2LL; 1×EDO; | ||||
| Assess | ||||||
| The first bromodomain of BRD4 with compound BDF-1253 | monomer | 1×96X; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BRD4-BD1 WITH COMPOUND 2 | monomer | 3×EDO; 1×O2Q; | ||||
| Assess | ||||||
| BRD4 bound with compound Bdi3 | monomer | 1×8F6; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor JWG069 | monomer | 1×F3J; 2×EDO; 1×NO3; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH : 8-(((1R,2R,3R,5S)-2-(2-(4,4-difluorocyclohexyl)ethyl)-8… | monomer | 1×EDO; 1×FZE; | ||||
| Assess | ||||||
| Complex structure of the first bromodomain of BRD4 with an inhibitor that containing a 2H-chromen-2… | monomer | 1×7UU; | ||||
| Assess | ||||||
| Brd4 Bromodomain 1 complex with 4-(2-OXO-1,3-OXAZOLIDIN-3-YL)BENZAMIDE inhibitor | monomer | 1×1A5; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH INHIBITOR JJ-II-131 | monomer | 1×XZG; 6×EDO; 1×NA; | ||||
| Assess | ||||||
| Crystal structure of hBRD4 in complex with BL-BI06 reveals a novel synthesized inhibitor that induc… | monomer | 1×4V1; 2×EDO; | ||||
| Assess | ||||||
| BRD4-BD1 bound with compound 40 | monomer | 1×EE9; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with benzo[cd]indol-2(1H)-one l… | monomer | 1×EB0; 1×EDO; 1×NO3; | ||||
| Assess | ||||||
| crystal structure of the first bromodomain of human BRD4 in complex with compound BDF-2143 | monomer | 1×ECU; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor SLP-50 | monomer | 2×JFU; | ||||
| Assess | ||||||
| Crystal Structure of BRD4(1) bound to Colchiceine | monomer | 2×NA; 1×2SJ; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with compound BDF-1038 | monomer | 1×EC3; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with compound BDF-2030 | monomer | 1×ECF; | ||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 (BD1) in complex with 6-[2-(diethylamino)ethoxy]-16-methoxy… | monomer | 1×D7F; 2×FMT; | ||||
| Assess | ||||||
| crystal structure of the first bromodomain of human BRD4 in complex with compound BDF-1024 | monomer | 1×EC0; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH BMS-986158, 2-{3-(1,4-dime… | monomer | 1×YWA; 3×IOD; 2×EDO; | ||||
| Assess | ||||||
| BRD4 Bromodomain 1 with an inhibitor | monomer | 1×99X; | ||||
| Assess | ||||||
| FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR N-{3-[4-(3-chlorophenyl)piperazin-… | monomer | 1×5D2; | ||||
| Assess | ||||||
| BRD4 bound with compound Bdi2 | monomer | 1×8F9; | ||||
| Assess | ||||||
| Complex structure of nitroxoline with the first bromodomain of BRD4 | monomer | 1×HNQ; | ||||
| Assess | ||||||
| Crystal structure of fragment bound with Brd4 | monomer | 1×64R; | ||||
| Assess | ||||||
| BRD4 bound with compound Bdi1 | monomer | 1×8FC; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with compound BDF-1021 | monomer | 1×EC9; | ||||
| Assess | ||||||
| The first bromodomain of BRD4 with compound BDF-2141 | monomer | 1×96R; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD4 bound to BI9564 | monomer | 1×5U6; | ||||
| Assess | ||||||
| BRD4-BD1 bound with ligand 103 | monomer | 1×BW6; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of BRD4 in complex with 16D10 | monomer | 1×4JI; 1×CL; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with the dual BET/HDAC inhibito… | monomer | 1×X8T; 5×EDO; | ||||
| Assess | ||||||
| Crystal Structure Analysis of the BRD4(1) | monomer | 1×EFM; 2×NO3; 3×EDO; 1×GOL; | ||||
| Assess | ||||||
| Triazole-based BET family bromodomain inhibitor bound to BRD4(D1) | monomer | 1×YNS; | ||||
| Assess | ||||||
| Bromodomain and Extra-terminal Domain (BET) BRD4 | monomer | 1×OWO; | ||||
| Assess | ||||||
| Cocrystal of BRD4(D1) with N,N-dimethyl-2-[(3R)-3-(5-{2-[2-methyl-5-(propan-2-yl)phenoxy]pyrimidin-… | monomer | 5×EDO; 1×2IR; 1×CL; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with benzo[cd]indol-2(1H)-one l… | monomer | 1×EB8; 2×NO3; 3×EDO; 3×GOL; | ||||
| Assess | ||||||
| Crystal Structure Analysis of the BRD4 | monomer | 1×8Q9; 2×NO3; 1×EDO; 2×GOL; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH BMT-206059 AKA 2-{(3M)-3-(… | monomer | 1×PQF; 1×NA; 2×EDO; | ||||
| Assess | ||||||
| N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH I-BET282 | monomer | 2×EDO; 1×UYK; | ||||
| Assess | ||||||
| BRD4 in complex with ERK5 inhibitor XMD8-92 | monomer | 1×4WG; | ||||
| Assess | ||||||
| Crystal Structure Analysis of the BRD4 | monomer | 1×8PU; 5×EDO; 1×NO3; 1×NA; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure Analysis of the BRD4 | monomer | 3×NO3; 2×EDO; 1×8PX; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 L94C variant in complex with racemic 3,5-d… | monomer | 1×E5Q; 1×V0R; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor PFi-1 | monomer | 1×0NS; 1×NA; 1×DMS; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with benzo[cd]indol-2(1H)-one l… | monomer | 2×NO3; 1×EB5; 1×GOL; 1×EDO; 2×DMS; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain of human BRD4 in complex with the inhibitor 16k | monomer | 1×HG8; 4×EDO; | ||||
| Assess | ||||||
| brd4-bd1 bound with ligand 167 | monomer | 1×BQ0; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with benzo[cd]indol-2(1H)-one l… | monomer | 2×EDO; 1×NO3; 1×EB7; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor 33 | monomer | 1×5FZ; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with benzo[cd]indol-2(1H)-one l… | monomer | 1×EB9; | ||||
| Assess | ||||||
| Crystal Structure of the First Bromodomain of Human BRD4 in Complex With Cyclic Vinylogous Amide In… | monomer | 1×5MJ; | ||||
| Assess | ||||||
| BRD4 second bromodomain (BD2) in complex with dual PI3 kinase (PI3K) inhibitor SF2558HA | monomer | 1×82Y; | ||||
| Assess | ||||||
| Peptide 4.2C in complex with BRD4.2 | monomer | 2×ACE; 2×NH2; | ||||
| Assess | ||||||
| Crystal structure of BRD4 bromodomain 1 (BD1) in complex with N2-(1,2,3-benzotriazol-5-yl)-N3-(dime… | monomer | 1×89T; | ||||
| Assess | ||||||
| Solution NMR structures of BRD4 first bromodomain with small compound MMQO | monomer | 1×MQO; | ||||
| Assess | ||||||
| BRD4 bromodomain 2 in complex with CD161 | monomer | 1×8FV; | ||||
| Assess | ||||||
| Bromodomain-containing protein 4 (BRD4) bromodomain 2 (BD2) complexed with XR844 | monomer | 1×7QZ; | ||||
| Assess | ||||||
| Human BRD4 C-terminal bromodomain with 1-(4-(3-methylbenzyl)-3,4-dihydroquinoxalin-1(2H)-yl)ethanone | monomer | 1×D7T; | ||||
| Assess | ||||||
| BRD4 bromodomain 2 in complex with gamma-carboline-containing compound, number 18. | monomer | 1×4LD; 1×EDO; | ||||
| Assess | ||||||
| BRD4 BD2 in complex with compound CE277 | monomer | 1×EO1; | ||||
| Assess | ||||||
| Bromodomain and Extra-terminal Domain (BET) BRD4 | monomer | 1×OWO; | ||||
| Assess | ||||||
| BRD4-BD2 in complex with the cyclic peptide 3.1_2 | monomer | 1×NH2; 1×GOL; | ||||
| Assess | ||||||
| C-TERMINAL BROMODOMAIN OF HUMAN BRD4 N-(2,2-diphenylethyl)-4-methoxy-3,5-dimethyl-N-(2-(methylamino… | monomer | 1×V9Z; | ||||
| Assess | ||||||
| Crystal Structure of the Bromo domain 2 in human Bromodomain Containing Protein 4 (BRD4) | monomer | 3×EDO; | ||||
| Assess | ||||||
| Crystal structure of the second bromodomain (BD2) of human BRD4 bound to SG3-179 | monomer | 1×5W2; 1×EDO; | ||||
| Assess | ||||||
| Bromodomain-containing protein 4 (BRD4) bromodomain 2 (BD2) complexed with YF3-126 | monomer | 1×YF6; 1×EDO; 1×GOL; | ||||
| Assess | ||||||
| Bivalent BET Bromodomain Inhibition | monomer | 1×6ON; | ||||
| Assess | ||||||
| Crystal structure of the second bromodomain of human BRD4 in complex with MS417 inhibitor | monomer | 2×0S6; 2×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the Second Bromodomain of Human Brd4 with the inhibitor GW841819X | monomer | 1×WSH; | ||||
| Assess | ||||||
| Crystal Structure of BRD4(1) bound to inhibitor BUX4 (13) | monomer | 1×L2N; | ||||
| Assess | ||||||
| BRD4_Bromodomain1-A1376855 | monomer | 1×8NG; 1×SO4; | ||||
| Assess | ||||||
| BRD4-BD2 in complex with the cyclic peptide 3.2_2 | monomer | 1×NH2; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor Y13153 | monomer | 1×JFR; 3×GOL; | ||||
| Assess | ||||||
| NMR2 structure of BRD4-BD2 in complex with iBET-762 | monomer | 1×EAM; | ||||
| Assess | ||||||
| BRD4 BD1 in complex with compound CF53 | monomer | 1×EO4; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH 2-{3-(1,4-dimethyl-1H-1,2,… | monomer | 2×YX4; | ||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor Y13157 | monomer | 1×JFL; 3×GOL; | ||||
| Assess | ||||||
| BRD4_BD2-A-35165 | monomer | 1×89J; | ||||
| Assess | ||||||
| BRD4_BD2_A-1342843 | monomer | 1×89G; | ||||
| Assess | ||||||
| BRD4 Bromodomain 2 with A-1359643 | monomer | 1×8NM; | ||||
| Assess | ||||||
| BRD4_BD2_A-1344772 | monomer | 1×87S; | ||||
| Assess | ||||||
| BRD4 Bromodomain 2 with A-1354689 | monomer | 1×8NP; | ||||
| Assess | ||||||
| BRD4_BD2_A-1461028 | monomer | 1×8O4; | ||||
| Assess | ||||||
| BRD4_BD2_A-1454056 | monomer | 1×8NV; | ||||
| Assess | ||||||
| BRD4_BD2_A-1390146 | monomer | 1×87M; | ||||
| Assess | ||||||
| BRD4_BD2_A-581577 | monomer | 1×88P; | ||||
| Assess | ||||||
| BRD4_BD2_A-1395017 | monomer | 1×87G; | ||||
| Assess | ||||||
| BRD4_BD2_A-1359930 | monomer | 1×87P; | ||||
| Assess | ||||||
| BRD4_BD2_A-556343 | monomer | 1×88Y; | ||||
| Assess | ||||||
| BRD4 Bromodomain 2 with A-1457066 | monomer | 1×8NS; | ||||
| Assess | ||||||
| BRD4-BD2 in complex with SF2523 | monomer | 1×82V; | ||||
| Assess | ||||||
| BRD4_BD2_A-1406537 | monomer | 1×8O1; | ||||
| Assess | ||||||
| BRD4 Bromodomain 2 with A-1349391 | monomer | 1×8NJ; | ||||
| Assess | ||||||
| BRD4_BD2_A-1107604 | monomer | 1×0S6; | ||||
| Assess | ||||||
| BRD4_BD2_A-1308586 | monomer | 1×87V; | ||||
| Assess | ||||||
| BRD4_BD2_A-1497627 | monomer | 1×89D; | ||||
| Assess | ||||||
| BRD4_Bromodomain1 complex with pyrrolopyridone compound 27 | monomer | 1×QYY; | ||||
| Assess | ||||||
| BRD4_BD2_A-1412838 | monomer | 1×88M; | ||||
| Assess | ||||||
| BRD4_Bromodomain1 complex with pyrrolopyridone compound 18 | monomer | 1×QYV; | ||||
| Assess | ||||||
| Solution structure of the second bromodomain of Brd4 | monomer | |||||
| Assess | ||||||
| BRD4-BD2 Ligand free | monomer | 4×EDO; 2×DMS; | ||||
| Assess | ||||||
| Bromodomain-containing 4 BD2 in complex with 3',4',7,8- Tetrahydroxyflavonoid | monomer | 1×SQH; | ||||
| Assess | ||||||
| BRD4_Bromodomain2 complex with pyrrolopyridone compound 18 | monomer | 1×QYV; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8ov6.1.C | monomer | 0.63 | 100.00 | |||
| Assess | ||||||